3,382 results on '"Shoushtari, A"'
Search Results
152. Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
- Author
-
Francis, Jasmine H., primary, Barker, Christopher A., additional, Canestraro, Julia, additional, Abramson, David H., additional, and Shoushtari, Alexander, additional
- Published
- 2024
- Full Text
- View/download PDF
153. Structural, magnetic and optical investigation of AC pulse electrodeposited zinc ferrite nanowires with different diameters and lengths
- Author
-
Ghazkoob, N., Zargar Shoushtari, M., Kazeminezhad, I., and Lari Baghal, S.M.
- Published
- 2021
- Full Text
- View/download PDF
154. Mucosal Melanoma
- Author
-
Henderson, Michael A., Balch, Charles M., Garbe, Claus, Shoushtari, Alexander N., Lian, Bin, Cui, Chuanliang, Guo, Jun, Balch, Charles M., editor, Atkins, Michael B., editor, Garbe, Claus, editor, Gershenwald, Jeffrey E., editor, Halpern, Allan C., editor, Kirkwood, John M., editor, McArthur, Grant A., editor, Thompson, John F., editor, and Sober, Arthur J., editor
- Published
- 2020
- Full Text
- View/download PDF
155. Online Deep Equilibrium Learning for Regularization by Denoising.
- Author
-
Jiaming Liu 0001, Xiaojian Xu 0002, Weijie Gan, Shirin Shoushtari, and Ulugbek Kamilov
- Published
- 2022
156. L5IN+: From an Analytical Platform to Optimization of Deep Inertial Odometry.
- Author
-
Hossein Shoushtari, Firas Kassawat, Dorian Harder, Korvin Venzke, Jörg Müller-Lietzkow, and Harald Sternberg
- Published
- 2022
157. Comparison of the effectiveness of flipped classroom and traditional teaching method on the components of self-determination and class perception among University students
- Author
-
MAHNAZ KHAYAT, FARIBA HAFEZI, PARVIZ ASGARI, and MARZIEH TALEBZADEH SHOUSHTARI
- Subjects
teaching ,self-determination ,students ,Education (General) ,L7-991 ,Medicine (General) ,R5-920 - Abstract
Introduction: The flipped classroom instruction can be an opportunity to make educational changes in class contents, which means this model can be a way to rethink learning and the educational process. The present study aimed to investigate the effectiveness of flipped classroom and traditional teaching methods on the components of self-determination and the class perception among university students.Methods: This is an experimental study with a pre-test and posttest design and a control group. The study population comprised of all female students of Farhangian University in Ahvaz city in theacademic year 2019. The sample consisted of 36 students selected by convenience sampling. We randomly divided the participants into experimental (n=18) and control (n=18) groups. The researchinstruments included the Basic Psychological Need Satisfaction and the Class Perception Questionnaire. The experimental group received the flipped teaching program during six 120-minutesessions once a week; however, the control group received the traditional teaching method. Data were analyzed by descriptive and inferential statistics, such as mean, standard deviation, analysis of covariance (ANCOVA), and multivariate analysis of covariance (MANCOVA).Results: The results indicated that there was a significant difference between the flipped classroom and traditional teaching (p
- Published
- 2021
- Full Text
- View/download PDF
158. New records of springtails (Hexapoda: Collembola) for Iran from Mazandaran forests
- Author
-
Eliye Yahyapour, Reza Vafaei Shoushtari, Masoumeh Shayanmehr, and Javier Arbea
- Subjects
hypogastruridae ,neanuridae ,tomoceridae ,Science (General) ,Q1-390 ,Life ,QH501-531 ,Zoology ,QL1-991 ,Agriculture ,Ecology ,QH540-549.5 - Abstract
Specimens of springtails were collected from soil and leaf litter in the forests of Mazandaran province, north of Iran during 2016–2017. Three species were recorded in this country for the first time, Xenylla szeptyckii Skarżyński, Piwnik & Porco, 2018 (Hypogastruridae), Friesea espunaensis Arbea & Jordana, 1993 (Neanuridae) and Tomocerina minuta (Tullberg, 1877) (Tomoceridae). Detailed descriptions of these species are provided based on the materials collected from Mazandaran province, Iran.
- Published
- 2021
159. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
- Author
-
Mathieu F. Bakhoum, Jasmine H. Francis, Albert Agustinus, Ethan M. Earlie, Melody Di Bona, David H. Abramson, Mercedes Duran, Ignas Masilionis, Elsa Molina, Alexander N. Shoushtari, Michael H. Goldbaum, Paul S. Mischel, Samuel F. Bakhoum, and Ashley M. Laughney
- Subjects
Science - Abstract
The molecular underpinnings driving uveal melanoma (UM) progression are unknown. Here the authors show that loss of Polycomb Repressive Complex 1 triggers chromosomal instability, which promotes inflammatory signaling and migration in UM.
- Published
- 2021
- Full Text
- View/download PDF
160. Avian Influenza-Killed Vaccine on Tissue Distribution and Shedding of Avian Influenza Virus H9N2 in Ducklings
- Author
-
M Abdi Haji, M Mayahi, Z Boroomand, and A Shoushtari
- Subjects
avian influenza virus h9n2 ,replication ,shedding ,vaccination ,ducklings ,Veterinary medicine ,SF600-1100 - Abstract
Ducks play an important role in the transmission of avian influenza to poultry farms. Because of the importance of vaccination in reducing virus shedding, this study evaluated avian influenza-killed vaccine H9N2 on tissue distribution and shedding of avian influenza virus H9N2 in ducklings. One hundred-day-old ducklings were purchased and, after bleeding from 20 birds, were kept in four separate rooms under standard conditions. Groups 1 and 2 were vaccinated at 9 days, and groups 2 and 3 were challenged with 0.1 ml of allantoic fluid containing 105 EID50 (A/chicken/Iran/Aid/2013(H9)) virus intranasally at 30 days. Group 4 chicks were kept as the control group. Chicks were observed two times daily. On days 1, 3, 5, and 8 after inoculation, 3 chicks were randomly selected from each group and cloaca and trachea swabs samples were collected from each bird. Then the ducklings were euthanized and trachea, lung, spleen, intestine, liver, and brain tissue samples were collected for molecular detection. The virus was detected in the tissues and tracheal and cloacal swabs by polymerase chain reaction (PCR), and anti-AIV titres were measured by HI test. The results showed no clinical signs in the challenged groups. In the vaccinated challenged group, virus was detected only in cloacal swabs, but in the unvaccinated challenged group, virus was detected more in tracheal swabs than in cloacal swabs. In challenged-unvaccinated chicks, virus was detected in the trachea and lungs, and in challenged-vaccinated birds, virus was detected in the intestines. In conclusion, vaccinating ducks against the AI H9N2 virus reduced shedding and tissue distribution of AI viruses in challenged ducks.
- Published
- 2021
- Full Text
- View/download PDF
161. A study to design minimum data set of COVID-19 registry system
- Author
-
Javad Zarei, Mohammad Badavi, Majid Karandish, Maryam Haddadzadeh Shoushtari, Maryam Dastoorpoor, Farid Yousefi, Hanieh Raji, and Maria Cheraghi
- Subjects
Minimum data set ,Registry system ,COVID-19 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background From the beginning of the COVID-19 pandemic, the development of infrastructures to record, collect and report COVID-19 data has become a fundamental necessity in the world. The disease registry system can help build an infrastructure to collect data systematically. The study aimed to design a minimum data set for the COVID-19 registry system. Methods A qualitative study to design an MDS for the COVID-19 registry system was performed in five phases at Ahvaz University of Medical Sciences in Khuzestan Province in southwestern Iran, 2020–2021. In the first phase, assessing the information requirements was performed for the COVID-19 registry system. Data elements were identified in the second phase. In the third phase, the MDS was selected, and in the four phases, the COVID-19 registry system was implemented as a pilot study to test the MDS. Finally, based on the experiences gained from the COVID-19 registry system implementation, the MDS were evaluated, and corrections were made. Results MDS of the COVID-19 registry system contains eight top groups including administrative (34 data elements), disease exposure (61 data elements), medical history and physical examination (138 data elements), findings of clinical diagnostic tests (101 data elements), disease progress and outcome of treatment (55 data elements), medical diagnosis and cause of death (12 data elements), follow-up (14 data elements), and COVID-19 vaccination (19 data elements) data, respectively. Conclusion Creating a standard and comprehensive MDS can help to design any national data dictionary for COVID-19 and improve the quality of COVID-19 data.
- Published
- 2021
- Full Text
- View/download PDF
162. Multiregional genetic evolution of metastatic uveal melanoma
- Author
-
Daniel A. Rodriguez, Jessica Yang, Michael A. Durante, Alexander N. Shoushtari, Stergios J. Moschos, Kazimierz O. Wrzeszczynski, J. William Harbour, and Richard D. Carvajal
- Subjects
Medicine ,Genetics ,QH426-470 - Abstract
Abstract Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and leads to deadly metastases for which there is no approved treatment. Genetic events driving early tumor development are well-described, but those occurring later during metastatic progression remain poorly understood. We performed multiregional genomic sequencing on 22 tumors collected from two patients with widely metastatic UM who underwent rapid autopsy. We observed multiple seeding events from the primary tumors, metastasis-to-metastasis seeding, polyclonal seeding, and late driver variants in ATM, KRAS, and other genes previously unreported in UM. These findings reveal previously unrecognized temporal and anatomic complexity in the genetic evolution of metastatic uveal melanoma, and they highlight the distinction between early and late phases of UM genetic evolution with implications for novel therapeutic approaches.
- Published
- 2021
- Full Text
- View/download PDF
163. The Effect of Redeployment During the COVID-19 Pandemic on Development of Anxiety, Depression, and Insomnia in Healthcare Workers
- Author
-
Martinez, Maylyn, Stewart, Nancy H., Koza, Anya L., Dhaon, Serena, Shoushtari, Christiana, and Arora, Vineet M.
- Published
- 2022
- Full Text
- View/download PDF
164. Linking interfacial energies with proton conductivity in sulfonated poly (ether ether ketone) nanocomposite
- Author
-
Esmaeilzadeh, Zahra, Karimi, Mohammad, Shoushtari, Ahmad Mousavi, and Javanbakht, Mehran
- Published
- 2021
- Full Text
- View/download PDF
165. Seismic performance of a two-span steel girder bridge with ABC connections
- Author
-
Shoushtari, Elmira, Saiidi, M. Saiid, Itani, Ahmad, and Moustafa, Mohamed A.
- Published
- 2021
- Full Text
- View/download PDF
166. Predominance of Fourth Panzootic Newcastle Disease Virus Subgenotype VII.1.1 in Iran and Its Relation to the Genotypes Circulating in the Region
- Author
-
Molouki, Aidin, Sotani, Mohammad, Fallah Mehrabadi, Mohammad Hossein, Shoushtari, Abdelhamid, Abtin, Alireza, Mahmoudzadeh Akhijahani, Mohsen, Abdoshah, Mohammad, Pourbakhsh, Seyed Ali, Allahyari, Esameel, Ghalyanchilangeroudi, Arash, Engelsma, Marc, and Lim, Swee Hua Erin
- Published
- 2021
- Full Text
- View/download PDF
167. Pomegranate extract supplementation improves lung function parameters and IL-35 expression in participants with mild and moderate persistent allergic asthma: A randomized, double-blind, placebo-controlled trial
- Author
-
Zainab Shateri, Seyed Ahmad Hosseini, Farhad Abolnezhadian, Elham Maraghi, Maryam Haddadzadeh Shoushtari, and Marzie Zilaee
- Subjects
asthma ,high-sensitivity C-reactive protein ,interleukin-35 ,lung function ,pomegranate ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Existing asthma treatments are associated with side effects and limitations, which has led to an interest in alternative and complementary therapies. Given the anti-inflammatory properties of pomegranate, the present study aimed to determine the impact of pomegranate extract supplementation on lung function parameters evaluated through spirometry, high-sensitivity C-reactive protein (hs-CRP), pro-oxidant antioxidant balance, and interleukin 35) (IL-35) in participants with mild and moderate allergic asthma (based on forced expiratory volume in 1 second (FEV1) and clinical symptoms). Participants with mild and moderate allergic asthma (n = 64) were randomly assigned to two groups: the intervention group, which received two pomegranate extract capsules (500 mg/day), or the control group for eight weeks. Also, the physician prescribed similar drugs to the participants in the study. Independent samples T-test and Mann–Whitney U were used to compare the quantitative outcomes between the intervention group and the comparison group. The Wilcoxon test and the paired T-test were applied for within-group comparisons. A p-value
- Published
- 2022
- Full Text
- View/download PDF
168. Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
- Author
-
Shaheer Khan, Sapna P. Patel, Alexander N. Shoushtari, Grazia Ambrosini, Serge Cremers, Shing Lee, Lauren Franks, Shahnaz Singh-Kandah, Susana Hernandez, Naomi Sender, Kristina Vuolo, Alexandra Nesson, Prabhjot Mundi, Benjamin Izar, Gary K. Schwartz, and Richard D. Carvajal
- Subjects
uveal melanoma ,metastatic ,MEK inhibition ,intermittent dosing ,selumetinib ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
IntroductionUveal melanoma (UM) is associated with poor outcomes in the metastatic setting and harbors activating mutations resulting in upregulation of MAPK signaling in almost all cases. The efficacy of selumetinib, an oral allosteric inhibitor of MEK1/2, was limited when administered at a continual dosing schedule of 75 mg BID. Preclinical studies demonstrate that intermittent MEK inhibition reduces compensatory pathway activation and promotes T cell activation. We hypothesized that intermittent dosing of selumetinib would reduce toxicity, allow for the administration of increased doses, and achieve more complete pathway inhibition, thus resulting in improved antitumor activity.MethodsWe conducted a phase Ib trial of selumetinib using an intermittent dosing schedule in patients with metastatic UM. The primary objective was to estimate the maximum tolerated dose (MTD) and assess safety and tolerability. Secondary objectives included assessment of the overall response rate (RR), progression-free survival (PFS) and overall survival (OS). Tumor biopsies were collected at baseline, on day 3 (on treatment), and between days 11-14 (off treatment) from 9 patients for pharmacodynamic (PD) assessments.Results29 patients were enrolled and received at least one dose of selumetinib across 4 dose levels (DL; DL1: 100 mg BID; DL2: 125 mg BID; DL3: 150 mg BID; DL4: 175 mg BID). All patients experienced a treatment-related adverse event (TRAE), with 5/29 (17%) developing a grade 3 or higher TRAE. Five dose limiting toxicities (DLT) were observed: 2/20 in DL2, 2/5 in DL3, 1/1 in DL4. The estimated MTD was 150 mg BID (DL3), with an estimated probability of toxicity of 29% (90% probability interval 16%-44%). No responses were observed; 11/29 patients achieved a best response of stable disease (SD). The median PFS and OS were 1.8 months (95% CI 1.7, 4.5) and 7.1 months (95% CI 5.3, 11.5). PD analysis demonstrated at least partial pathway inhibition in all samples at day 3, with reactivation between days 11-14 in 7 of those cases.ConclusionsWe identified 150 mg BID as the MTD of intermittent selumetinib, representing a 100% increase over the continuous dose MTD (75 mg BID). However, no significant clinical efficacy was observed using this dosing schedule.
- Published
- 2022
- Full Text
- View/download PDF
169. Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
- Author
-
Alexander Z. Wei, Matan Uriel, Agata Porcu, Michael P. Manos, Ann C. Mercurio, Michael M. Caplan, Liam Hulse, Rino S. Seedor, Marta Holovatska, Jasmine Francis, Shaheer A. Khan, Diana E. McDonnell, Dmitry Bogomolny, Takami Sato, Brian P. Marr, Rizwan Haq, Marlana Orloff, Alexander Shoushtari, and Richard D. Carvajal
- Subjects
uveal melanoma ,brain metastases ,cutaneous melanoma ,mucosal melanoma ,acral melanoma ,ocular oncology ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Metastatic uveal melanoma (mUM) is an advanced ocular malignancy characterized by a hepatotropic pattern of spread. As the incidence of brain metastases (BM) in mUM patients has been thought to be low, routine CNS surveillance has not been recommended. Notably, no formal assessment of BM incidence in mUM has to date been published to support this clinical practice. We aimed to determine the true rate of BM in mUM and to clarify the clinical and genomic risk factors associated with BM patients through a collaborative multicenter, retrospective research effort. Data collected from 1,845 mUM patients in databases across four NCI-designated comprehensive cancer centers from 2006-2021 were retrospectively analyzed to identify patients with BM. Brain imaging in most cases were performed due to onset of neurological symptoms and not for routine surveillance. An analysis of demographics, therapies, gene expression profile, tumor next generation sequencing (NGS) data, time to metastasis (brain or other), and survival in the BM cohort was completed. 116/1,845 (6.3%) mUM patients were identified with BM. The median age at time of UM diagnosis was 54 years old (range: 18-77). The median time to any metastasis was 4.2 years (range: 0-30.8). The most common initial metastatic site was the liver (75.9%). 15/116 (12.9%) BM patients presented with BM at the time of initial metastatic diagnosis. Median survival after a diagnosis of BM was 7.6 months (range: 0.4-73.9). The median number of organs involved at time of BM diagnosis was 3 (range: 1-9). DecisionDX-UM profiling was completed on 13 patients: 10-Class 2, 2-Class 1B, and 1-Class 1A. NGS and cytogenetic data were available for 34 and 21 patients, respectively. BM was identified in 6.3% of mUM cases and was associated with high disease burden and a median survival of under 8 months once diagnosed. Since most patients in this cohort were symptomatic, the incidence of asymptomatic BM remains unknown. These data suggest the use of routine brain imaging in all mUM patients at risk for developing BM for early detection.
- Published
- 2022
- Full Text
- View/download PDF
170. Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer
- Author
-
David S. Hong, Ajay K. Gopal, Alexander N. Shoushtari, Sandip P. Patel, Aiwu R. He, Toshihiko Doi, Suresh S. Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B. Davis, Timothy S. Fisher, Bo Huang, Kolette D. Fly, and Antoni Ribas
- Subjects
utomilumab ,4-1BB/CD137 ,immune checkpoint inhibitor ,melanoma ,NSCLC ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Section HeadClinical/translational cancer immunotherapyBackgroundThe goal of this study was to estimate the objective response rate for utomilumab in adults with immune checkpoint inhibitor (ICI)-refractory melanoma and non–small-cell lung cancer (NSCLC).MethodsUtomilumab was dosed intravenously every 4 weeks (Q4W) and adverse events (AEs) monitored. Tumor responses by RECIST1.1 were assessed by baseline and on-treatment scans. Tumor biopsies were collected for detection of programmed cell death ligand 1, CD8, 4-1BB, perforin, and granzyme B, and gene expression analyzed by next-generation sequencing. CD8+ T cells from healthy donors were stimulated with anti-CD3 ± utomilumab and compared with control.ResultsPatients with melanoma (n=43) and NSCLC (n=20) received utomilumab 0.24 mg/kg (n=36), 1.2 mg/kg (n=26), or 10 mg/kg (n=1). Treatment-emergent AEs (TEAEs) occurred in 55 (87.3%) patients and serious TEAEs in 18 (28.6%). Five (7.9%) patients discontinued owing to TEAEs. Thirty-two (50.8%) patients experienced treatment-related AEs, mostly grade 1–2. Objective response rate: 2.3% in patients with melanoma; no confirmed responses for patients with NSCLC. Ten patients each with melanoma (23.3%) or NSCLC (50%) had stable disease; respective median (95% confidence interval, CI) progression-free survival was 1.8 (1.7–1.9) and 3.6 (1.6–6.5) months. Utomilumab exposure increased with dose. The incidences of antidrug and neutralizing antibodies were 46.3% and 19.4%, respectively. Efficacy was associated with immune-active tumor microenvironments, and pharmacodynamic activity appeared to be blunted at higher doses.ConclusionsUtomilumab was well tolerated, but antitumor activity was low in patients who previously progressed on ICIs. The potential of 4-1BB agonists requires additional study to optimize efficacy while maintaining the tolerable safety profile.
- Published
- 2022
- Full Text
- View/download PDF
171. Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
- Author
-
Shaheer Khan, Jose Lutzky, Alexander N. Shoushtari, Joanne Jeter, Brian Marr, Thomas E. Olencki, Colleen M. Cebulla, Mohamed Abdel-Rahman, J. William Harbour, Naomi Sender, Alexandra Nesson, Shahnaz Singh-Kandah, Susana Hernandez, Jeanelle King, Manpreet S. Katari, Lyssa Dimapanat, Stephanie Izard, Grazia Ambrosini, Oliver Surriga, Alex J. Rai, Codruta Chiuzan, Gary K. Schwartz, and Richard D. Carvajal
- Subjects
uveal melanoma ,high-risk ,adjuvant therapy ,crizotinib ,extracellular vesicles ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
IntroductionApproximately 40% of patients with uveal melanoma (UM) will develop metastatic disease. Tumors measuring at least 12mm in basal diameter with a class 2 signature, as defined by a widely used gene expression-profiling test, are associated with significantly higher risk of metastasis, with a median time to recurrence of 32 months. No therapy has been shown to reduce this risk.Materials and MethodsThis was a single-arm, multicenter study in patients with high-risk UM who received definitive treatment of primary disease and had no evidence of metastasis. Patients were consecutively enrolled to receive 12 four-week cycles of adjuvant crizotinib at a starting dose of 250mg twice daily and were subsequently monitored for 36 months. The primary outcome of this study was to assess recurrence-free survival (RFS) of patients with high-risk UM who received adjuvant crizotinib.Results34 patients enrolled and received at least one dose of crizotinib. Two patients were unevaluable due to early withdrawal and loss to follow-up, leaving 32 patients evaluable for efficacy. Eight patients (25%) did not complete the planned 48-week course of treatment due to disease recurrence (n=5) or toxicity (n=3). All patients experienced at least one adverse event (AE), with 11/34 (32%) experiencing a Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or 4 AE. After a median duration of follow up of 47.1 months, 21 patients developed distant recurrent disease. The median RFS was 34.9 months (95% CI (Confidence Interval), 23-55 months), with a 32-month recurrence rate of 50% (95% CI, 33-67%). Analysis of protein contents from peripheral blood extracellular vesicles in a subset of patient samples from baseline, on-treatment, and off-treatment, revealed a change in protein content associated with crizotinib exposure, however without a clear association with disease outcome.ConclusionsThe use of adjuvant crizotinib in patients with high-risk UM did not result in improved RFS when compared to historical controls. Analysis of blood extracellular vesicles revealed changes in protein content associated with treatment, raising the possibility of future use as a biomarker. Further investigation of adjuvant treatment options are necessary for this challenging disease.
- Published
- 2022
- Full Text
- View/download PDF
172. Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
- Author
-
Weber, Jeffrey S., Poretta, Tayla, Stwalley, Brian D., Sakkal, Leon A., Du, Ella X., Wang, Travis, Chen, Yan, Wang, Yan, Betts, Keith A., and Shoushtari, Alexander N.
- Published
- 2023
- Full Text
- View/download PDF
173. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
- Author
-
Amaria, Rodabe N., Postow, Michael, Burton, Elizabeth M., Tetzlaff, Michael T., Ross, Merrick I., Torres-Cabala, Carlos, Glitza, Isabella C., Duan, Fei, Milton, Denái R., Busam, Klaus, Simpson, Lauren, McQuade, Jennifer L., Wong, Michael K., Gershenwald, Jeffrey E., Lee, Jeffrey E., Goepfert, Ryan P., Keung, Emily Z., Fisher, Sarah B., Betof-Warner, Allison, Shoushtari, Alexander N., Callahan, Margaret, Coit, Daniel, Bartlett, Edmund K., Bello, Danielle, Momtaz, Parisa, Nicholas, Courtney, Gu, Aidi, Zhang, Xuejun, Korivi, Brinda Rao, Patnana, Madhavi, Patel, Sapna P., Diab, Adi, Lucci, Anthony, Prieto, Victor G., Davies, Michael A., Allison, James P., Sharma, Padmanee, Wargo, Jennifer A., Ariyan, Charlotte, and Tawbi, Hussein A.
- Published
- 2023
- Full Text
- View/download PDF
174. Early Detection of Avian Diseases Based on Thermography and Artificial Intelligence
- Author
-
Mohammad Sadeghi, Ahmad Banakar, Saeid Minaei, Mahdi Orooji, Abdolhamid Shoushtari, and Guoming Li
- Subjects
avian disease ,poultry ,precision livestock farming ,machine learning ,thermography ,Veterinary medicine ,SF600-1100 ,Zoology ,QL1-991 - Abstract
Non-invasive measures have a critical role in precision livestock and poultry farming as they can reduce animal stress and provide continuous monitoring. Animal activity can reflect physical and mental states as well as health conditions. If any problems are detected, an early warning will be provided for necessary actions. The objective of this study was to identify avian diseases by using thermal-image processing and machine learning. Four groups of 14-day-old Ross 308 Broilers (20 birds per group) were used. Two groups were infected with one of the following diseases: Newcastle Disease (ND) and Avian Influenza (AI), and the other two were considered control groups. Thermal images were captured every 8 h and processed with MATLAB. After de-noising and removing the background, 23 statistical features were extracted, and the best features were selected using the improved distance evaluation method. Support vector machine (SVM) and artificial neural networks (ANN) were developed as classifiers. Results indicated that the former classifier outperformed the latter for disease classification. The Dempster–Shafer evidence theory was used as the data fusion stage if neither ANN nor SVM detected the diseases with acceptable accuracy. The final SVM-based framework achieved 97.2% and 100% accuracy for classifying AI and ND, respectively, within 24 h after virus infection. The proposed method is an innovative procedure for the timely identification of avian diseases to support early intervention.
- Published
- 2023
- Full Text
- View/download PDF
175. Systematic review and meta analysis of differential attrition between active and control arms in randomized controlled trials of lifestyle interventions in chronic disease
- Author
-
Bevens W, Shoushtari A, Jelinek P, Jelinek GA, and Weiland TJ
- Subjects
Chronic disease ,Attrition ,Lifestyle ,Retention ,Medicine (General) ,R5-920 - Abstract
Abstract Background Attrition is a major obstacle for lifestyle interventions sustained for the medium-to-long term and can have significant consequences on the internal validity of a trial. When the degree of attrition differs between active and control arms this is termed differential attrition and is an important consideration during initial stages of trial planning. Objectives The primary research question of this study was: what is the differential attrition between treatment arms in lifestyle interventions for prevalent chronic diseases? Methods We performed a systematic review and meta-analysis of 23 studies involving a lifestyle intervention component in cohorts with chronic diseases. The search accessed three databases: Scopus, Medline Ovid and Web of Science. Attrition between treatment arms was analysed using a random-effects model and examined the relationship between the relative attrition and potential moderators, such as time to final follow-up, time to first follow-up, type of disease, type of control, type of intervention and length of treatment. Results The pooled risk ratio was 1.00 (95% CI 0.97 – 1.03) and only one study fell outside this range. A univariable association was described between the pooled risk ration and length (years) to final follow-up, which did not remain in the multivariable model. Conclusions Ultimately, we found no evidence of differential attrition in medium-to-long term lifestyle intervention studies for chronic disease, increasing confidence in conducting such studies with minimal potential of attrition bias. Trial registration PROSPERO registration number CRD42018084495 .
- Published
- 2021
- Full Text
- View/download PDF
176. Fabrication of hydrophilic and hydrophobic silica aerogel by drying at ambient pressure and their structural properties
- Author
-
M Zargar Shoushtari and N Navazesh
- Subjects
silica aerogel ,superhydrophobic ,ambient pressure ,sol-gel ,nanostructure ,Physics ,QC1-999 - Abstract
In this research, silica aerogel was made by sol-gel method with sodium silicate precursor and drying at ambient temperature. The silica aerogel prepared by this method is superhydrophobic. To make it hydrophilic, the sample was heated at 400 °C for 2 h. The structure of the samples was studied using X-ray diffraction, scanning electron microscopy, adsorption and desorption of nitrogen gas. To investigate the hydrophilicity and hydrophobicity of the samples, the water droplet contact surface test was performed. The chemical bonds of the prepared samples were studied using Fourier transform infrared spectroscopy. The overall results showed that the size of the particles and the pores increase and become smaller, respectively when the hydrophilicity of the silica aerogel sample changes to the hydrophobic sample. The angle of contact of the water droplet with the surface of the hydrophobic sample is 170°, while reaches to 51° for the hydrophilic sample.
- Published
- 2021
- Full Text
- View/download PDF
177. Corrosion performance of polypyrrole-coated metals: A review of perspectives and recent advances
- Author
-
Zadeh, Maryam Kahvazi, Yeganeh, Mahdi, Shoushtari, Mohammadreza Tavakoli, and Esmaeilkhanian, Amirhossein
- Published
- 2021
- Full Text
- View/download PDF
178. Photocatalytic degradation of 4-Nitrophenol by g-C3N4-MCy: Mechanism study and kinetic modeling
- Author
-
Abbasi, Zahra, García-López, Elisa I., Marcì, Giuseppe, Farrokhnia, Abdolhadi, and Shoushtari, Morteza Zargar
- Published
- 2021
- Full Text
- View/download PDF
179. Circulation of at Least Six Distinct Groups of Pigeon-Derived Newcastle Disease Virus in Iran Between 1996 and 2019
- Author
-
Molouki, Aidin, Soltani, Mohammad, Akhijahani, Mohsen Mahmoudzadeh, Merhabadi, Mohammad Hossein Fallah, Abtin, Alireza, Shoushtari, Abdelhamid, Langeroudi, Arash Ghalyanchi, Lim, Swee Hua Erin, Allahyari, Esmaeel, Abdoshah, Mohammad, and Pourbakhsh, Seyed Ali
- Published
- 2021
- Full Text
- View/download PDF
180. Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
- Author
-
Algazi, Alain P, Tsai, Katy K, Shoushtari, Alexander N, Munhoz, Rodrigo R, Eroglu, Zeynep, Piulats, Josep M, Ott, Patrick A, Johnson, Douglas B, Hwang, Jimmy, Daud, Adil I, Sosman, Jeffrey A, Carvajal, Richard D, Chmielowski, Bartosz, Postow, Michael A, Weber, Jeffrey S, and Sullivan, Ryan J
- Subjects
Prevention ,Rare Diseases ,Clinical Research ,Cancer ,Clinical Trials and Supportive Activities ,Evaluation of treatments and therapeutic interventions ,6.2 Cellular and gene therapies ,6.1 Pharmaceuticals ,Adult ,Aged ,Aged ,80 and over ,Antibodies ,Monoclonal ,Antibodies ,Monoclonal ,Humanized ,Antineoplastic Combined Chemotherapy Protocols ,B7-H1 Antigen ,Female ,Follow-Up Studies ,Humans ,Male ,Melanoma ,Middle Aged ,Mucous Membrane ,Neoplasm Staging ,Nivolumab ,Prognosis ,Programmed Cell Death 1 Receptor ,Retrospective Studies ,Skin Neoplasms ,Survival Rate ,Uveal Neoplasms ,atezolizumab ,immunotherapy ,nivolumab ,pembrolizumab ,uveal melanoma ,Oncology and Carcinogenesis ,Public Health and Health Services ,Oncology & Carcinogenesis - Abstract
BackgroundAntibodies inhibiting the programmed death receptor 1 (PD-1) have demonstrated significant activity in the treatment of advanced cutaneous melanoma. The efficacy and safety of PD-1 blockade in patients with uveal melanoma has not been well characterized.MethodsFifty-eight patients with stage IV uveal melanoma received PD-1 or PD-1 ligand (PD-L1) antibodies between 2009 and 2015 at 9 academic centers. Patients who were evaluable for response were eligible for the analysis. Imaging was performed every 12 weeks and at the investigators' discretion. Safety and clinical efficacy outcomes, including the best overall response, progression-free survival (PFS), and overall survival (OS), were retrospectively determined.ResultsOf 56 eligible patients, 48 (86%) had received prior therapy, and 35 (63%) had received treatment with ipilimumab. Three patients had an objective response to ipilimumab, and 8 had stable disease as their best response. Thirty-eight patients (68%) received pembrolizumab, 16 (29%) received nivolumab, and 2 (4%) received atezolizumab. Objective tumor responses were observed in 2 patients for an overall response rate of 3.6% (95% confidence interval [CI], 1.8%-22.5%). Stable disease (≥6 months) was observed in 5 patients (9%). The median PFS was 2.6 months (95% CI, 2.4-2.8 months), and the median OS was 7.6 months (95% CI, 0.7-14.6 months). There was no association between prior treatment with ipilimumab or liver-directed therapy and PFS or OS. Treatment was well tolerated, and only 1 patient discontinued treatment because of toxicity.ConclusionsPD-1 and PD-L1 antibodies rarely confer durable remissions in patients with metastatic uveal melanoma. Clinical trial enrollment should be prioritized in this population. Cancer 2016;122:3344-3353. © 2016 American Cancer Society.
- Published
- 2016
181. The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma
- Author
-
Shoushtari, Alexander N, Munhoz, Rodrigo R, Kuk, Deborah, Ott, Patrick A, Johnson, Douglas B, Tsai, Katy K, Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J, Luke, Jason J, Gangadhar, Tara C, Salama, April KS, Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B, Algazi, Alain P, Ribas, Antoni, Wolchok, Jedd D, and Postow, Michael A
- Subjects
Clinical Trials and Supportive Activities ,Cancer ,Clinical Research ,Adult ,Aged ,Aged ,80 and over ,Antibodies ,Monoclonal ,Antibodies ,Monoclonal ,Humanized ,Antineoplastic Combined Chemotherapy Protocols ,Brain Neoplasms ,Female ,Follow-Up Studies ,Humans ,Liver Neoplasms ,Male ,Melanoma ,Middle Aged ,Mucous Membrane ,Neoplasm Staging ,Nivolumab ,Prognosis ,Programmed Cell Death 1 Receptor ,Retrospective Studies ,Skin Neoplasms ,Survival Rate ,acral melanoma ,anti-programmed cell death receptor 1 ,immunotherapy ,mucosal melanoma ,nivolumab ,pembrolizumab ,Oncology and Carcinogenesis ,Public Health and Health Services ,Oncology & Carcinogenesis - Abstract
BackgroundTherapeutic antibodies against programmed cell death receptor 1 (PD-1) are considered front-line therapy in metastatic melanoma. The efficacy of PD-1 blockade for patients with biologically distinct melanomas arising from acral and mucosal surfaces has not been well described.MethodsA multi-institutional, retrospective cohort analysis identified adults with advanced acral and mucosal melanoma who received treatment with nivolumab or pembrolizumab as standard clinical practice through expanded access programs or published prospective trials. Objective responses were determined using investigator-assessed Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. Progression-free survival and overall survival were assessed using the Kaplan-Meier method.ResultsSixty individuals were identified, including 25 (42%) with acral melanoma and 35 (58%) with mucosal melanoma. Fifty-one patients (85%) had received previous therapy, including 77% who had previously received ipilimumab. Forty patients (67%) received pembrolizumab at a dose of 2 mg/kg or 10 mg/kg, and 20 (33%) received nivolumab at a doses ranging from 0.3 to 10 mg/kg every 2 to 3 weeks. The objective response rate was 32% (95% confidence interval, 15%-54%) in patients with acral melanoma and 23% (95% confidence interval, 10%-40%) in those with mucosal melanoma. After a median follow-up of 20 months in the acral melanoma group and 10.6 months in the mucosal melanoma group, the median progression-free survival was 4.1 months and 3.9 months, respectively. Only 2 patients (3%) discontinued treatment because of toxicity.ConclusionsResponse rates to PD-1 blockade in patients with acral and mucosal melanomas were comparable to the published rates in patients with cutaneous melanoma and support the routine use of PD-1 blockade in clinical practice. Further investigation is needed to identify the mechanisms of response and resistance to therapy in these subtypes. Cancer 2016;122:3354-3362. © 2016 American Cancer Society.
- Published
- 2016
182. Analytical studies and design of steel plate girder ABC bridges under seismic loads
- Author
-
Shoushtari, Elmira, Saiidi, M. Saiid, Itani, Ahmad, and Moustafa, Mohamed A.
- Published
- 2021
- Full Text
- View/download PDF
183. Secrecy Coding for the Binary Symmetric Wiretap Channel via Linear Programming
- Author
-
Nikkhah, Ali, Shoushtari, Morteza, Akhbari, Bahareh, Harrison, Willie K., Nikkhah, Ali, Shoushtari, Morteza, Akhbari, Bahareh, and Harrison, Willie K.
- Abstract
In this paper, we use a linear programming (LP) optimization approach to evaluate the equivocation for a wiretap channel where the main channel is noiseless, and the wiretap channel is a binary symmetric channel (BSC). Using this technique, we present an analytical limit for the achievable secrecy rate in the finite blocklength regime that is tighter than traditional fundamental limits. We also propose a secrecy coding technique that outperforms random binning codes. When there is one overhead bit, this coding technique is optimum and achieves the analytical limit. For cases with additional bits of overhead, our coding scheme can achieve equivocation rates close to the new limit. Furthermore, we evaluate the patterns of the generator matrix and the parity-check matrix for linear codes and we present binning techniques for both linear and non-linear codes using two different approaches: recursive and non-recursive. To our knowledge, this is the first optimization solution for secrecy coding obtained through linear programming., Comment: Submitted for possible Journal publication
- Published
- 2024
184. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
- Author
-
Bart Neyns, Lisa Zimmer, Caroline Robert, Celeste Lebbe, Olivier Michielin, Omid Hamid, Anne Zaremba, Oliver Klein, Ruth Plummer, Joanna Mangana, Paolo A Ascierto, Katharina C Kähler, Georgina V Long, Ryan Sullivan, Grant A McArthur, Michael Weichenthal, Egle Ramelyte, Meghan J Mooradian, Douglas B Johnson, Alexander Shoushtari, Christian U Blank, Judith M Versluis, Prachi Bhave, Claudia Trojanello, Lu Si, Inderjit Mehmi, Tasnia Ahmed, Alexander M Menzies, Adnan Khattak, Severine Roy, Matteo S Carlino, Paul C Lorigan, Clara Allayous, Rachel Roberts-Thomson, Florentia Dimitriou, Kathleen Batty, Thierry Lesimple, Serigne N Lo, Alexandre Wicky, Richard Heywood, Lena Tran, Anna Stansfeld, Julia K Schwarze, Andrea Maurichi, Hui-Ling Yeoh, Mario Santinami, and Andrew M Haydon
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Acral melanoma is a rare melanoma subtype with poor prognosis. Importantly, these patients were not identified as a specific subgroup in the landmark melanoma trials involving ipilimumab and the anti-programmed cell death protein-1 (PD-1) agents nivolumab and pembrolizumab. There is therefore an absence of prospective clinical trial evidence regarding the efficacy of checkpoint inhibitors (CPIs) in this population. Acral melanoma has lower tumor mutation burden (TMB) than other cutaneous sites, and primary site is associated with differences in TMB. However the impact of this on the effectiveness of immune CPIs is unknown. We examined the efficacy of CPIs in acral melanoma, including by primary site.Methods Patients with unresectable stage III/IV acral melanoma treated with CPI (anti-PD-1 and/or ipilimumab) were studied. Multivariable logistic and Cox regression analyses were conducted. Primary outcome was objective response rate (ORR); secondary outcomes were progression-free survival (PFS) and overall survival (OS).Results In total, 325 patients were included: 234 (72%) plantar, 69 (21%) subungual and 22 (7%) palmar primary sites. First CPI included: 184 (57%) anti-PD-1, 59 (18%) anti-PD-1/ipilimumab combination and 82 (25%) ipilimumab. ORR was significantly higher with initial anti-PD-1/ipilimumab compared with anti-PD-1 (43% vs 26%, HR 2.14, p=0.0004) and significantly lower with ipilimumab (15% vs 26%, HR 0.49, p=0.0016). Landmark PFS at 1 year was highest for anti-PD-1/ipilimumab at 34% (95% CI 24% to 49%), compared with 26% (95% CI 20% to 33%) with anti-PD-1 and 10% (95% CI 5% to 19%) with ipilimumab. Despite a trend for increased PFS, anti-PD-1/ipilimumab combination did not significantly improve PFS (HR 0.85, p=0.35) or OS over anti-PD-1 (HR 1.30, p=0.16), potentially due to subsequent therapies and high rates of acquired resistance. No outcome differences were found between primary sites.Conclusion While the ORR to anti-PD-1/ipilimumab was significantly higher than anti-PD-1 and PFS numerically higher, in this retrospective cohort this benefit did not translate to improved OS. Future trials should specifically include patients with acral melanoma, to help determine the optimal management of this important melanoma subtype.
- Published
- 2022
- Full Text
- View/download PDF
185. Combination intravitreous melphalan and bevacizumb for cutaneous metastatic melanoma to the vitreous and retina
- Author
-
Jasmine H. Francis, Julia Canestraro, David H. Abramson, Christopher A. Barker, and Alexander N. Shoushtari
- Subjects
Melphalan ,Metastatic melanoma ,Bevacizumab ,Neovascularization ,Vitreous ,Retina ,Ophthalmology ,RE1-994 - Abstract
Purpose: Cutaneous melanoma metastatic to the vitreous/retina is rare but increasingly common. Due to the potential of recurrent disease with current treatment options and the propensity for these eyes to develop neovascularization, these eyes can pose a treatment challenge and novel management strategies are needed. This case series explores the use of combination, sequential intravitreous melphalan and bevacizumab. Observation: Two eyes of two patients with cutaneous melanoma metastatic to the vitreoretina were eye treated with combination intravitreous melphalan (10-30 mcg) and bevacizumab (1.25 mg) given sequentially during the same office visit, at monthly intervals. Both cases had control of disease at 7- and 12-months follow up. Furthermore, treatment reversed neovascular glaucoma and dramatically improved vision in the eye of one patient; and stabilized vision without the development of neovascularization in the eye of the other patient. There were no ocular adverse events noted in either eye. Conclusions and Importance: Combination, sequential intravitreous melphalan and bevacizumab is well-tolerated and an attractive approach for treating eyes with intraocular metastatic melanoma.
- Published
- 2022
- Full Text
- View/download PDF
186. Specific human endogenous retroviruses predict metastatic potential in uveal melanoma
- Author
-
Matthew L. Bendall, Jasmine H. Francis, Alexander N. Shoushtari, and Douglas F. Nixon
- Subjects
Microbiology ,Oncology ,Medicine - Abstract
Uveal melanoma (UM) is a unique disease in that patients with primary UM are well stratified based on their risk of developing metastasis, yet there are limited effective treatments once metastases occur. There is an urgent need to better understand the distinct molecular pathogenesis of UM and the characteristics of patients at high risk for metastasis to identify neoantigenic targets that can be used in immunotherapy and to develop novel therapeutic strategies that may effectively target this lethal transition. An important and overlooked area of molecular pathogenesis and neoantigenic targets in UM comes from human endogenous retroviruses (HERVs). We investigated the HERV expression landscape in primary UM and found that tumors were stratified into 4 HERV-based subsets that provide clear delineation of risk outcome and support subtypes identified by other molecular indicators. Specific HERV loci are associated with the risk of uveal melanoma metastasis and may offer mechanistic insights into this process, including dysregulation of HERVs on chromosomes 3 and 8. A HERV signature composed of 17 loci was sufficient to classify tumors according to subtype with greater than 95% accuracy, including at least 1 intergenic HERV with coding potential (HERVE_Xp11.23) that could represent a potential HERV E target for immunotherapy.
- Published
- 2022
- Full Text
- View/download PDF
187. The Association between Self-Compassion and Academic Well-Being with the Mediating Role of Perceived Academic Stress and Academic Optimism in Female Students
- Author
-
Zahra Shirmohammadi, Zahra Eftekhar Saadi, and Marzieh Talebzadeh Shoushtari
- Subjects
academic well-being ,self-compassion ,stress ,optimism ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Academic well-being is among the most recent concepts of positive psychology, which greatly contributes to the students’ sense of security and health in the academic setting and improves their academic performance. The study aimed to investigate the association between self-compassion and academic well-being with the mediating role of perceived academic stress and academic optimism in female students in Kermanshah, Iran. Methods: The study was a descriptive correlation. The statistical population comprised all the female high-school students in Kermanshah in the academic year 2020-2021. Through the use of stratified random sampling method, 226 of the female students were selected as the sample. The research tools included the Academic Well-Being Scale, the Self-Compassion Scale, the Academic Stress Questionnaire, and the Life Orientation Test. The path analysis method was used to investigate the proposed model. Results: The results showed that there was a direct and crucial association between self-compassion and academic optimism (P
- Published
- 2021
- Full Text
- View/download PDF
188. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
- Author
-
Ilad Alavi Darazam, Shervin Shokouhi, Mohamad Amin Pourhoseingholi, Seyed Sina Naghibi Irvani, Majid Mokhtari, Minoosh Shabani, Mahdi Amirdosara, Parham Torabinavid, Maryam Golmohammadi, SayedPayam Hashemi, Arsalan Azimi, Mohammad Hossein Jafarazadeh Maivan, Omidvar Rezaei, Alireza Zali, Mohammadreza Hajiesmaeili, Hadiseh Shabanpour Dehbsneh, Akram Hoseyni Kusha, Maryam Taleb Shoushtari, Negar Khalili, Azam Soleymaninia, Latif Gachkar, and Ali Khoshkar
- Subjects
Medicine ,Science - Abstract
Abstract Type 1 Interferons (IFNs) have been associated with positive effects on Coronaviruses. Previous studies point towards the superior potency of IFNβ compared to IFNα against viral infections. We conducted a three-armed, individually-randomized, open-label, controlled trial of IFNβ1a and IFNβ1b, comparing them against each other and a control group. Patients were randomly assigned in a 1:1:1 ratio to IFNβ1a (subcutaneous injections of 12,000 IU on days 1, 3, 6), IFNβ1b (subcutaneous injections of 8,000,000 IU on days 1, 3, 6), or the control group. All three arms orally received Lopinavir/Ritonavir (400 mg/100 mg twice a day for ten days) and a single dose of Hydroxychloroquine 400 mg on the first day. Our utilized primary outcome measure was Time To Clinical Improvement (TTCI) defined as the time from enrollment to discharge or a decline of two steps on the clinical seven-step ordinal scale, whichsoever came first. A total of 60 severely ill patients with positive RT-PCR and Chest CT scans underwent randomization (20 patients to each arm). In the Intention-To-Treat population, IFNβ1a was associated with a significant difference against the control group, in the TTCI; (HR; 2.36, 95% CI 1.10–5.17, P-value = 0.031) while the IFNβ1b indicated no significant difference compared with the control; HR; 1.42, (95% CI 0.63–3.16, P-value = 0.395). The median TTCI for both of the intervention groups was five days vs. seven days for the control group. The mortality was numerically lower in both of the intervention groups (20% in the IFNβ1a group and 30% in the IFNβ1b group vs. 45% in the control group). There were no significant differences between the three arms regarding the adverse events. In patients with laboratory-confirmed SARS-CoV-2 infection, as compared with the base therapeutic regiment, the benefit of a significant reduction in TTCI was observed in the IFNβ1a arm. This finding needs further confirmation in larger studies. Trial Registration Number: ClinicalTrials.gov, NCT04343768. (Submitted: 08/04/2020; First Online: 13/04/2020) (Registration Number: NCT04343768).
- Published
- 2021
- Full Text
- View/download PDF
189. Outbreak Investigation of Officially Reported and Highly Pathogenic Avian Influenza (H5N8 Subtype) in Iran During 2016
- Author
-
M. H Fallah Mehrabadi, F Tehrani, A Shoushtari, A. R Bahonar, M. H Rabiee, A Ghalyanchilangeroudi, S. A Ghafouri, and S Amirhajloo
- Subjects
hpai h5n8 ,iran ,outbreak investigation ,Veterinary medicine ,SF600-1100 - Abstract
On 14 November 2016, an outbreak of highly pathogenic avian influenza (HPA) was reported from a commercial layer farm located in Malard, Tehran Province, Iran. This study aimed to investigate the HPAI H5N8 outbreaks in Iran. The questionnaire was prepared and completed through interviews with farm owners or field observations at the time of disease onset from November 2016 to February 2017. The HPAI H5N8 infection was confirmed in 30 different locations including 10 villages (33.3%), nine-layer farms (33%), two broiler breeder farms (6.67%), one layer breeder farm (3.3%), one turkey farm (3.3%), one partridge farm (3.3%), five national parks (16.7%), and one wetland (3.3%) in 12 provinces of Iran. The cumulative incidence rates of disease in villages, layer farms, broiler breeder farms, layer breeder farms, partridge farms, and turkey farms were 0.02%, 0.87%, 0.55%, 6.25%, 7.14%, and 0.69%, respectively. The findings reflect that among the investigated variables at infected locations, new birds entering the home in villages, live bird markets, inappropriate biosecurity conditions, transporting manure during the breeding period, close proximity of a common road to infected farms, and poultry movement inside (pullet) and outside were the most frequently observed possible risk factors for these outbreaks. In conclusion, attention should be focused on the study of the dynamics and movements of domestic poultry, investigation and modification of the structure of industrial poultry farms, training for all related people, enhancement of passive surveillance, an increase in biosecurity, raising the awareness of the authorities on the importance of the infection, and provision of the required credits and facilities.
- Published
- 2021
- Full Text
- View/download PDF
190. Calibration of seasonal transfer equation (Z–R) by data of Doppler weather radar, rainfall gauging station and genetic algorithm method in the Abolabbas watershed (in southwest of Iran)
- Author
-
Arash Adib, Masoud Soori Damirchi Sofla, Seyed Yahya Mirzaei, Mohammad Mahmoudian Shoushtari, and Ali Liaghat
- Subjects
abolabbas watershed ,doppler weather radar ,genetic algorithm ,hec-hms rainfall–runoff model ,transfer function z–r ,Water supply for domestic and industrial purposes ,TD201-500 ,River, lake, and water-supply engineering (General) ,TC401-506 - Abstract
The observed radar reflectivity (Z) converts to rainfall intensity (R) by a transfer function. In the first stage, for calibration of collected data (with time step 15 minutes) by weather radar and determination of the best relation between Z and R, it applied a genetic algorithm (GA) to minimize the amount of root mean square error (RMSE). Although Z = 166R2 (the transfer function in the Khuzestan province of Iran) is an appropriate equation, the GA method distinguished that Z = 110R1.8 (from February to May) and Z = 126R2 (for other months) are the optimum transfer functions for the Abolabbas watershed in Iran. The mean of RMSE of optimum transfer equations is 0.59 mm/hr in the calibration stage and 0.85 mm/hr in the verification stage. In the second stage, the Hydrologic Modeling System (HEC-HMS model) used four types of precipitation data (extracted rainfall data from radar and the optimum transfer equations, Z = 166R2, Z = 200R1.6 and extracted rainfall data from rainfall gauging stations). The calibrated rainfall data by the optimum transfer equations can produce flood hydrographs in which their accuracy is similar to the accuracy of generated flood hydrographs by collected rainfall data of rainfall gauging stations. The mean of RMSE is 0.65 cubic metres per second and the mean or R2 is 0.89 for optimum transfer equations. HIGHLIGHTS Extraction of the function Z–R for a watershed.; Using time intervals less than 1 hr for rainfall hyetographs (15 minutes).; Using an optimization method for determination of the transfer function Z–R and considering seasonal characteristics of precipitation that can distinguish two transfer functions Z–R.; Using a rainfall–runoff model for determination of accuracy of the derived functions Z–R.;
- Published
- 2021
- Full Text
- View/download PDF
191. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
- Author
-
Cristina Valero, Mark Lee, Douglas Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli, Paul K. Paik, George Plitas, Marc Ladanyi, Michael A. Postow, Charlotte E. Ariyan, Alexander N. Shoushtari, Vinod P. Balachandran, A. Ari Hakimi, Aimee M. Crago, Kara C. Long Roche, J. Joshua Smith, Ian Ganly, Richard J. Wong, Snehal G. Patel, Jatin P. Shah, Nancy Y. Lee, Nadeem Riaz, Jingming Wang, Ahmet Zehir, Michael F. Berger, Timothy A. Chan, Venkatraman E. Seshan, and Luc G. T. Morris
- Subjects
Science - Abstract
There is an unmet clinical need for simple, accessible biomarkers to select patients who are more likely to respond to immune checkpoint therapy. Here the authors show that a lower neutrophil-to-lymphocyte ratio is associated with better overall and progressive-free survival, as well as higher rate of response, in a multi-cancer cohort of patients treated with immune checkpoint inhibitors.
- Published
- 2021
- Full Text
- View/download PDF
192. More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
- Author
-
Conor M. Prendergast, Kathleen M. Capaccione, Egesta Lopci, Jeeban P. Das, Alexander N. Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, and Dorine De Jong
- Subjects
melanoma ,CAR T-cell ,metastases ,radiomics ,PET radiotracers ,CAR T-cell imaging ,Medicine (General) ,R5-920 - Abstract
Advanced melanoma is one of the deadliest cancers, owing to its invasiveness and its propensity to develop resistance to therapy. Surgery remains the first-line treatment for early-stage tumors but is often not an option for advanced-stage melanoma. Chemotherapy carries a poor prognosis, and despite advances in targeted therapy, the cancer can develop resistance. CAR T-cell therapy has demonstrated great success against hematological cancers, and clinical trials are deploying it against advanced melanoma. Though melanoma remains a challenging disease to treat, radiology will play an increasing role in monitoring both the CAR T-cells and response to therapy. We review the current imaging techniques for advanced melanoma, as well as novel PET tracers and radiomics, in order to guide CAR T-cell therapy and manage potential adverse events.
- Published
- 2023
- Full Text
- View/download PDF
193. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents
- Author
-
Jonathan Moreno, Khalid Zoghebi, David Salehi, Lois Kim, Sorour Khayyatnejad Shoushtari, Rakesh K. Tiwari, and Keykavous Parang
- Subjects
amphiphilic ,cyclic peptides ,intracellular transportation ,protein delivery ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
The entry of proteins through the cell membrane is challenging, thus limiting their use as potential therapeutics. Seven cell-penetrating peptides, designed in our laboratory, were evaluated for the delivery of proteins. Fmoc solid-phase peptide synthesis was utilized for the synthesis of seven cyclic or hybrid cyclic–linear amphiphilic peptides composed of hydrophobic (tryptophan (W) or 3,3-diphenylalanine (Dip) and positively-charged arginine (R) residues, such as [WR]4, [WR]9, [WWRR]4, [WWRR]5, [(RW)5K](RW)5, [R5K]W7, and [DipR]5. Confocal microscopy was used to screen the peptides as a protein delivery system of model cargo proteins, green and red fluorescein proteins (GFP and RFP). Based on the confocal microscopy results, [WR]9 and [DipR]5 were found to be more efficient among all the peptides and were selected for further studies. [WR]9 (1–10 µM) + protein (GFP and RFP) physical mixture did not show high cytotoxicity (>90% viability) in triple-negative breast cancer cells (MDA-MB-231) after 24 h, while [DipR]5 (1–10 µM) physical mixture with GFP exhibited more than 81% cell viability. Confocal microscopy images revealed internalization of GFP and RFP in MDA-MB-231 cells using [WR]9 (2–10 μM) and [DipR]5 (1–10 µM). Fluorescence-activated cell sorting (FACS) analysis indicated that the cellular uptake of GFP was concentration-dependent in the presence of [WR]9 in MDA-MB-231 cells after 3 h of incubation at 37 °C. The concentration-dependent uptake of GFP and RFP was also observed in the presence of [DipR5] in SK-OV-3 and MDA-MB-231 cells after 3 h of incubation at 37 °C. FACS analysis indicated that the cellular uptake of GFP in the presence of [WR]9 was partially decreased by methyl-β-cyclodextrin and nystatin as endocytosis inhibitors after 3 h of incubation in MDA-MB-231 cells, whereas nystatin and chlorpromazine as endocytosis inhibitors slightly reduced the uptake of GFP in the presence of [DipR]5 after 3 h of incubation in MDA-MB-231. [WR]9 was able to deliver therapeutically relevant proteins (Histone H2A) at different concentrations. These results provide insight into the use of amphiphilic cyclic peptides in the delivery of protein-related therapeutics.
- Published
- 2023
- Full Text
- View/download PDF
194. Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors
- Author
-
Shahin Tahan Shoushtari, Jocelyn Gal, Emmanuel Chamorey, Renaud Schiappa, Olivier Dassonville, Gilles Poissonnet, Déborah Aloi, Médéric Barret, Inga Safta, Esma Saada, Anne Sudaka, Dorian Culié, and Alexandre Bozec
- Subjects
laryngeal carcinoma ,hypopharyngeal carcinoma ,larynx preservation ,total laryngectomy ,salvage surgery ,Medicine - Abstract
Background: The aims of this study were to compare the survival outcomes of salvage vs. primary total laryngectomy (TL) in patients with locally advanced laryngeal or hypopharyngeal carcinoma and to determine their predictive factors. Methods: Overall (OS), cause-specific (CSS) and recurrence-free survival (RFS) of primary vs. salvage TL were compared in univariate and multivariate analysis taking into account other potential predictive factors (tumor site, tumor stage, comorbidity level etc.). Results: A total of 234 patients were included in this study. Five-year OS was 53% and 25% for the primary and salvage TL groups, respectively. Multivariate analysis confirmed the independent negative impact of salvage TL on OS (p = 0.0008), CSS (p < 0.0001) and RFS (p < 0.0001). Hypopharyngeal tumor site, ASA score ≥ 3, N-stage ≥ 2a and positive surgical margins were the main other predictors of oncologic outcomes. Conclusions: Salvage TL is associated with significantly worse survival rates than primary TL highlighting the need for careful selection of patients who are candidates for larynx preservation. The predictive factors of survival outcomes identified here should be considered in the therapeutic decision-making, especially in the setting of salvage TL, given the poor prognosis of these patients.
- Published
- 2023
- Full Text
- View/download PDF
195. Thermodynamic investigation of asphaltene precipitation and deposition profile in wellbore: A case study
- Author
-
Shoushtari, Amin Baghal, Asadolahpour, Seyed Reza, and Madani, Mohammad
- Published
- 2020
- Full Text
- View/download PDF
196. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
- Author
-
Yang, Chen, Sanchez-Vega, Francisco, Chang, Jason C., Chatila, Walid K., Shoushtari, Alexander N., Ladanyi, Marc, Travis, William D., Busam, Klaus J., and Rekhtman, Natasha
- Published
- 2020
- Full Text
- View/download PDF
197. Diagnostic and Therapeutic Challenges of Rare Concurrent Intracranial Meningioma and Oligodendroglioma.
- Author
-
Shoushtari, Ali, Robinson, Lorraina, Mao, Qinwen, Shah, Lubdha M., Salzman, Karen L., and Menacho, Sarah T.
- Subjects
- *
MENINGIOMA , *MAGNETIC resonance imaging , *BRAIN tumors - Abstract
Concurrent primary brain tumors are rare clinical entities, with a prevalence ranging from 0.1 to 0.5% of all diagnosed brain tumors. The co-occurrence of meningioma and oligodendroglioma is particularly uncommon, posing unique diagnostic and therapeutic challenges. We describe the case of a patient diagnosed with concurrent meningioma and oligodendroglioma and review the existing literature on this rare phenomenon.Introduction: A 55-year-old female patient with a history of seizures presented to the emergency department with worsening headaches, nausea, and vomiting. She had a known right frontoparietal intracranial mass but had previously declined surgery. Magnetic resonance imaging revealed extensive fluid-attenuated inversion recovery /T2 hyperintensity around the lesion, which had slowly increased over 5 years; the growth of the lesion was producing a mass effect with a significant midline shift. The patient underwent urgent hemicraniectomy with subsequent resection. Clinical evaluation, imaging studies, and histopathological examination were conducted to confirm the diagnosis. Genetic and molecular analyses were also performed to explore potential underlying mechanisms. Histopathological findings confirmed a diagnosis of an isocitrate dehydrogenase-mutated World Health Organization Grade II oligodendroglioma with 1p/19q codeletion, along with a Grade I meningioma.Case Presentation: The coexistence of meningioma and oligodendroglioma represents a rare clinical event. Surgical management remains the cornerstone of treatment. Further investigation into the genetic and environmental factors that contribute to the co-occurrence of such tumors could pave the way for more targeted therapeutic strategies. [ABSTRACT FROM AUTHOR]Conclusion: - Published
- 2024
- Full Text
- View/download PDF
198. The Effectiveness of Emotional Schema Therapy on Self-Regulation and Frustration Tolerance in Female Students with Exam Anxiety.
- Author
-
Mousavi, Sara, Heidari, Alireza, Safarzadeh, Sahar, Asgari, Parviz, and Shoushtari, Marzieh Talebzadeh
- Published
- 2024
- Full Text
- View/download PDF
199. Effects of Emotionally Focused Therapy on Emotional Autonomy and Emotion Regulation of Students with Depression Symptoms.
- Author
-
Mousavi, Fatemeh Seyed, Shoushtari, Marzieh Talebzadeh, and Safarzadeh, Sahar
- Published
- 2024
- Full Text
- View/download PDF
200. Detecting Vulnerability in Hardware Description Languages: Opcode Language Processing.
- Author
-
Ayar, Alaaddin Goktug, Sahruri, Abdullah, Aygun, Sercan, Moghadam, Mehran Shoushtari, Najafi, M. Hassan, and Margala, Martin
- Abstract
Detecting vulnerable code blocks has become a highly popular topic in computer-aided design, especially with the advancement of natural language processing (NLP). Analyzing hardware description languages (HDLs), such as Verilog, involves dealing with lengthy code. This letter introduces an innovative identification of attack-vulnerable hardware by the use of opcode processing. Leveraging the advantage of architecturally defined opcodes and expressing all operations at the beginning of each code line, the word processing problem is efficiently transformed into opcode processing. This research converts a benchmark dataset into an intermediary code stack, subsequently classifying secure and fragile codes using NLP techniques. The results reveal a framework that achieves up to 94% accuracy when employing sophisticated convolutional neural networks (CNNs) architecture with extra embedding layers. Thus, it provides a means for users to quickly verify the vulnerability of their HDL code by inspecting a supervised learning model trained on the predefined vulnerabilities. It also supports the superior efficacy of opcode-based processing in Trojan detection by analyzing the outcomes derived from a model trained using the HDL dataset. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.